Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
As a leading provider of CAR-T cell therapy development services, Creative Biolabs offers cutting-edge solutions to accelerate the development and production of innovative cell therapies. Leveraging the latest advancements in nanotechnology, Creative Biolabs has revolutionized the field of CAR-T cell therapy by enhancing the targeting and delivery of therapeutic molecules to cancer cells. With a team of experienced scientists and engineers, we offer a comprehensive range of services, including nanoparticle synthesis, characterization, and validation to support the development of personalized cell therapies.
Nanoparticles play a crucial role in cell therapy by serving as delivery vehicles for therapeutic molecules. These tiny particles can encapsulate drugs, proteins, or genetic materials and target specific cells within the body, allowing for precise and efficient treatment. By using nanoparticles, scientists can increase the stability and bioavailability of the therapeutic agents, as well as enhance their ability to penetrate cell membranes. Additionally, nanoparticles can be modified to release their cargo in a controlled manner, ensuring a sustained and effective treatment.
Creative Biolabs' nanoparticle-based T cell platform utilizes engineered nanoparticles to enhance the capabilities of T cells for targeted cancer therapy. These nanoparticles are designed to deliver specific antigens or signaling molecules to T cells, activating them in a precise and controlled manner. By harnessing the power of T cells, which are a critical component of the immune system's ability to recognize and destroy cancer cells, our platform potentially improves the efficacy and specificity of cancer treatment. Additionally, the use of nanoparticles allows for the delivery of multiple therapeutic agents in a single platform, providing a more comprehensive and personalized approach to cancer therapy.
Designing nanoparticles to mimic antigen-presenting cells
Enhancing targeting and delivery to specific T cell subsets
Incorporating cytokines and immunomodulatory molecules
Co-delivering multiple therapeutic agents
Optimizing nanoparticle properties for improved T-cell interaction
Incorporating imaging and tracking capabilities
Enhanced Tumor Penetration
Nanoparticles can be engineered to improve the penetration of CAR-T cells into solid tumors, which conventional CAR-T cells may struggle to reach. This can enhance the efficacy of treatment for solid tumors.
Increased Persistence
Nanoparticles can be designed to prolong the persistence of CAR-T cells in the body, increasing their efficacy and reducing the likelihood of cancer relapse.
Enhanced Safety
Nanoparticles can also be used to deliver protective agents to CAR-T cells, reducing the risk of toxicity and adverse side effects associated with CAR-T cell therapy.
Nanoparticle-based T-cell therapy has shown potential for various applications, such as cancer immunotherapy, autoimmune disease treatment, and viral infection control. By targeting and modulating the function of T cells, this technology enhances the efficacy and specificity of T cell-based therapies.
If you are interested in learning more about our nanoparticle-based CAR-T cell therapy development service, please contact us today. Our team of experts is standing by to answer any questions you may have and discuss how this innovative approach can benefit your research and preclinical trials.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
